Group exercise program for women after breast cancer treatment
Strength After Breast Cancer: Clinical Implementation of an Evidence-based Group Exercise Intervention for Breast Cancer Survivors
This study is testing a group exercise program for women who have finished breast cancer treatment to see if it helps them stay active and feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | MGH Institute of Health Professions Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT06052488 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility of the Strength After Breast Cancer (SABC) program, a group exercise intervention designed for women who have completed treatment for breast cancer. Conducted at Massachusetts General Hospital, participants will undergo a physical therapy evaluation and engage in a four-session exercise program that includes both group and home-based activities. The study will assess the practicality of delivering this program in an outpatient setting and identify barriers and facilitators to its implementation. Participants will complete questionnaires and interviews to provide feedback on their experience and the program's effectiveness.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older who have been diagnosed with Stage I-III breast cancer and have completed their primary cancer treatment.
Not a fit: Patients with medical conditions that prevent safe exercise or those who do not speak English may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve physical function and quality of life for women recovering from breast cancer.
How similar studies have performed: Previous studies have shown that similar exercise interventions can improve physical function in breast cancer survivors, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years of age * Diagnosed with Stage I-III breast cancer, having completed primary cancer treatment (e.g., surgery, chemotherapy, radiation therapy); hormonal therapies and adjuvant targeted therapies will be permitted Exclusion Criteria: * Any injury or medical condition that would prohibit being able to safely perform exercise as indicated by the Physical Activity Readiness Questionnaire (i.e., atrial fibrillation, chest pain or angina, uncontrolled high blood pressure or hypertension, loss of balance due to dizziness in the past 12 months, or loss of consciousness in the past 12 months). * Non-English speaking
Where this trial is running
Boston, Massachusetts
- MGH Institute of Health Professions — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Stephen Wechsler, DPT, PhD — MGH Institute of Health Professions
- Study coordinator: Stephen Wechsler, DPT, PhD
- Email: swechsler@mghihp.edu
- Phone: 774-217-3221
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.